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AbstrAct
Objective To investigate feasibility of multiple sclerosis 
(MS) exercise guidelines for inactive people with MS 
(PwMS) and to examine preliminary efficacy for walking. 
To investigate effect of augmenting that intervention with 
education based on social cognitive theory (SCT).
Design Pilot multicentre, double-blind, randomised, 
parallel, controlled trial.
setting Community-delivered programme.
Participants Sixty-five physically inactive PwMS walked 
independently, scored 0–3 on the Patient Determined 
Disease Steps Scale, had no MS relapse or change in MS 
medication in 12 weeks.
Interventions 10-week exercise plus SCT education 
(SCT) compared with exercise plus attention control 
education (CON).
Outcome measures Six-Minute Walk Test (6MWT), Timed 
Up and Go (TUG) test and Multiple Sclerosis Walking 
Scale-12 (MSWS-12).
results 174 expressed interest, 92 were eligible and 
65 enrolled (SCT, n=32; CON, n=33). The intervention 
was feasible and delivered as intended. 68% of SCT 
group and 50% of control group met the exercise 
guidelines after intervention. Using linear mixed 
effects models, intention-to-treat basis, there was 
insufficient evidence for difference between the groups 
over the trial (6MWT, p=0.30; TUG, p=0.4; MSWS-12, 
p=0.8). Using secondary analysis of a cohort with data 
for≥3 assessments (SCT, n=21; CON, n=20), there was 
significant treatment effect favouring the intervention 
group (p=0.04) with mean effect for 6MWT 39.0 m 
(95% CI 2.26 to 75.73) at 12 weeks and 40.0 m (95% CI 
2.3 to 77.8) at 36 weeks. Both groups improved 
significantly in 6MWT following 10-week intervention 
(SCT, mean ∆=83.02, SD=60.1, p≤0.01; CON, mean 
∆=56.92, SD=73.5, p≤0.01), TUG (SCT, ∆=−0.70, 
SD=1.25, p≤0.01; CON, ∆=−0.54, SD=0.95, p≤0.01) 
and MSWS-12 (SCT, ∆=−8.03, SD=16.18, p=0.02; CON, 
∆=−0.86, SD=18.74, p=0.81).
conclusions A 10-week exercise programme based 
on the MS exercise guidelines for improving walking 
in previously inactive PwMS was feasible. There is 
marginal evidence of a treatment effect in favour of the 
exercise plus SCT intervention at 12 and  
36 weeks.
trial registration number NCT02301442; Results.
IntrODuctIOn
Walking limitations are the hallmark of 
multiple sclerosis (MS)1 and people with 
MS (PwMS) report that walking limitations 
are a significant concern.2 Indeed, walking 
limitations have been associated with change 
in occupation due to MS and occupational 
disability3 and influence a range of other 
outcomes such as cognition and depression.4 
Exercise training remains the cornerstone 
therapeutic intervention for the management 
of walking limitations in MS. Many studies 
report positive effects from a range of exer-
cise interventions as summarised in recent 
reviews5 and meta-analyses6 7 that confirm 
combined aerobic and resistance exercises 
can improve both walking speed and walking 
endurance.
The recent exercise guidelines recommend 
aerobic exercise twice a week and resistance 
exercise twice a week as the minimum target 
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Research
strengths and limitations of this study
 ► New evidence demonstrating the feasibility and 
preliminary efficacy of delivering a pragmatic, 
combined, community-based exercise and social 
cognitive theory education intervention for physically 
inactive people with multiple sclerosis  (MS) based 
on the MS Exercise Guideline.
 ► The use of measures of fidelity, assessments of the 
target variables of the intervention (strength, fitness 
and physical activity) and both self-report and 
objective measures of walking mobility.
 ► Treatment fidelity was considered and evaluated, 
yet a limitation relates to the use of a 1-day training 
course for physiotherapists, in particular relating to 
the novel use of education techniques throughout 
the exercise programme.
 ► Attrition of participants between determining 
eligibility and starting the intervention; the long wait 
times meant that 29% of eligible participants were 
lost at this phase.
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for improving walking outcomes among people with 
mild-to-moderate MS.8 To that end, we demonstrated 
using a pragmatic, randomised controlled trial design, 
that 10 weeks of combined aerobic and resistance training 
delivered in groups in the community yielded positive 
improvements in Six-Minute Walk Test (6MWT).9 Of 
concern, however, was that these improvements were not 
maintained at 3-month follow-up.10
The maintenance of long-term exercise behaviour 
change is not a problem that is unique to MS, and 
researchers have highlighted the need for inclusion of 
behavioural approaches based on theory for long-term 
behaviour change.11 Social cognitive theory (SCT) has 
been most commonly investigated in MS and its domains 
of exercise self-efficacy and goal setting are consistently 
associated with physical activity (PA) behaviour.12 We have 
reported improvements in PA and secondary outcomes 
including walking, from an SCT-based online intervention 
in MS,13 and one study demonstrated that PA behaviour 
change was maintained 3 months after cessation of the 
program.14 This education programme was originally 
designed based on a Randomised Controlled Trial (RCT) 
of a SCT-based exercise intervention delivered in older 
adults15 and later modified and tested for MS.16
We designed a randomised controlled pilot trial called 
‘Step it Up’17 that combined a group exercise programme 
with a theory-based education component for augmenting 
the effect of exercise on walking outcomes and sustaining 
these changes over time. The aim of this study was to 
investigate the feasibility of delivering the combined 
interventions by physiotherapists and to establish prelim-
inary clinical efficacy for improving walking outcomes; 
secondary outcomes will be provided in a parallel publi-
cation. We delivered the same exercise programme to 
both groups and controlled for contact by comparing a 
structured SCT education programme with an attention 
control education programme and investigated whether 
adding the SCT education component would yield 
greater improvements in walking mobility and whether 
the improvements were maintained at follow-up. It was 
hypothesised that that the participants in the exercise 
and SCT-based intervention would achieve significantly 
more improvement in walking outcomes than the control 
group postintervention and that this improvement would 
be maintained at follow-up. The results of this trial will 
inform the design, particularly power analysis, of a defini-
tive trial that provides Class 1 evidence (AAN).
MethODs
study design
This was a multicentre, two-arm, parallel (1:1), double-
blind, randomised controlled trial.
setting and participants
The participants were recruited through the MS Society 
of Ireland and via neurology clinics in three urban loca-
tions in Ireland. Details of the recruitment process are 
further detailed in the protocol paper.17 Inclusion criteria 
were: (1) physician-confirmed formal diagnosis of MS, (2) 
aged 18 years or more, (3) Patient Determined Disease 
Steps (PDDS) Scale score of 0–3, (4) a sedentary lifestyle 
(<30 min of moderate to strenuous exercise 1 day or more 
per week over the last 6 months) and (5) willing to give 
written informed consent. Exclusion criteria included: 
(1) pregnancy, (2) MS relapse in the previous 12 weeks 
and (3) changes to MS medication or steroid treatment in 
the previous 12 weeks. Participants were sent the consent 
form in advance of the baseline assessment, and written 
consent was obtained in person.
randomisation and blinding
Participants were randomly allocated into the exer-
cise plus SCT-based intervention or the exercise plus 
contact control education intervention. Random allo-
cation procedures have been previously outlined17 and 
were adhered to. JN generated the random allocation 
sequence, the SH enrolled participants and SC assigned 
participants to interventions. The outcome assessor (SH) 
was blind to allocation throughout the study as was the 
statistician CS during the analysis. All participants were 
informed that the study aimed to examine the effect of 
combining exercise and education, and therefore were 
blinded regarding group allocation.
screening questionnaire
Potential participants were screened for eligibility for 
this study using a questionnaire that included the PDDS 
Scale,18 confirmation of formal MS diagnosis and ques-
tions regarding PA levels. The PDDS scale contains a 
single item for measuring self-reported neurological 
impairment on an ordinal level from zero (Normal) to 
eight (Bedridden). Scores from the PDDS are linearly and 
strongly related with physician-administered Expanded 
Disability Status Scale (EDSS) scores.18
Outcome measures
Outcome measures were conducted preintervention 
(week 1), postintervention (week 12) and at 24-week and 
36-week follow-up.
Demographic and clinical information
Participants provided details regarding age, gender, level 
of formal education, time since diagnosis of MS, duration 
of symptoms of MS, falls history, exercise history, marital 
status and employment status. Additionally, a researcher 
formally trained in the use of the EDSS (SH) adminis-
tered the EDSS to all participants at baseline. The EDSS 
quantifies MS disease progression and is commonly the 
standard that other outcome measures are compared 
against.19 It consists of functional systems subscales and 
a total score which is an ordinal rating ranging from 0 
(normal neurological status) to 10 (death due to MS). 
MS diagnosis according to the McDonald or Poser 
criteria was confirmed from the participant’s consultant 
neurologist.
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Primary outcomes
The primary outcome was walking mobility at week 
36. This was measured using the 6MWT as the primary 
endpoint. The participants were instructed to walk as 
quickly and as safely as possible for 6 min on a 10-metre 
track. The 6MWT has demonstrated excellent test-retest 
reliability and concurrent validity among people with 
mild-to-moderate MS.20
We further used the Timed Up and Go test (TUG) and 
the Multiple Sclerosis Walking Scale-12 (MSWS-12). The 
TUG has demonstrated excellent test-retest reliability 
for people with mild MS21 and the MSWS-12 has demon-
strated excellent internal consistency,22 23 test-retest reli-
ability24 and concurrent validity in PwMS.25
Adherence
Adherence to the intervention was documented 
throughout the 10-week intervention via exercise logs 
(see online supplementary appendix 1 Exercise Logs). 
The exercise logs captured attendance at the exercise 
classes and home exercise sessions. Over the 10-week 
intervention, 44 total sessions were made available to 
the participants. This included six exercise classes with 
strengthening and coaching/education components, 
four coaching phone calls, 14 prescribed home strength-
ening sessions and 20 prescribed home walking sessions.
We further evaluated adherence to the exercise 
component by evaluating the effect on strength, fitness 
and PA. The five times sit to stand test (5xSTS)26 (time 
to complete five sit to stand repetitions in seconds) 
measured lower extremity muscle strength. The Modified 
Canadian Aerobic Fitness Test27 measured fitness and was 
calculated using following equation; 10 x (17.2 + (1.29 x 
O2 cost of last stage) – (0.09 x body mass in kg) – (0.18 
x Age)). The Health Index of the Godin Leisure-Time 
Exercise Questionnaire28 measured PA behaviour. These 
measures and associated psychometric properties have 
been described in the trial protocol.17
Interventions
The content of the interventions delivered in both arms 
of this RCT has been outlined in detail in the protocol 
paper17 and is further outlined in online supplementary 
appendix 2 (TIDieR checklist). The exercise interven-
tion was common to both groups and was delivered by 
physiotherapists. The aim of the exercise component was 
to progressively increase the intensity of both aerobic 
and strengthening activities to enable the participants 
to reach the published exercise guidelines for people 
with mild-to-moderate MS,8 and has been previously 
described.17 Over the 10-week programme, participants 
attended the group exercise class (see online supple-
mentary appendix 3 Exercises) at community venues on 
six occasions, supplemented with a telephone coaching 
call in the weeks without classes (intervention weeks 4, 
6, 7 and 9). After each of the group exercise classes, the 
control group received an education session about topics 
unrelated to PA behaviour, for example, diet, vitamin D, 
sleep, temperature and hydration and immunisations 
and vaccinations. The exercise plus SCT-based interven-
tion group received the same exercise intervention as the 
control group (as described in the previous section). This 
group also received a similar duration of education based 
on the principles of SCT for health behaviour change, 
namely: self-efficacy, outcome expectations, goal-setting, 
barriers and benefits and has been previously described.17 
The SCT intervention was designed to enable continued 
exercise behaviour and after the 10-week intervention the 
participants in both groups received structured phone 
calls from the intervention physiotherapists at weeks 16, 
20 and 36. These telephone calls consisted of direct ques-
tions about the frequency, intensity, type and duration of 
exercise participants had completed and whether they 
had experienced any adverse events or relapses. Addition-
ally the SCT group was coached using the principles of 
that educational component.
treatment fidelity
All of the physiotherapists who delivered the interven-
tion or control group sessions were provided with a 1-day 
training course on the delivery of the intervention for 
their group, directly related to the manual of operating 
procedures.17 The intervention was delivered at three 
sites over the course of the study by eight physiothera-
pists broadly representative of those working in primary 
care. Continued support from the research centre was 
available if additional training was needed. The fidelity 
of the physiotherapists’ sessions, including both exercise 
and SCT components, was monitored by randomly allo-
cated video and audio recording of at least one of the 
intervention sessions. An independent assessor compared 
the content of the intervention manuals with the video or 
audio recordings.
statistical analysis
Sample size
Consistent with data from a large international study,29 
it was hypothesised that the effect of the intervention 
would yield an average improvement in 6MWT distance 
of 36 m with an estimated SD of 48.2 m. In order to have 
80% power (at the 5% significance level) to detect such a 
difference in mean improvement in 6MWT over the study 
period between groups, a sample of size 62 randomised 
equally to two arms (ie, 31 per arm) was used to inform 
the target sample size for this pilot study. The intention 
was to recruit 72 participants to account for dropout and 
to run the group interventions once sufficient people 
in that region were eligible. Recruitment in regions was 
not uniform and participants became ineligible while 
waiting for others to be recruited. Recruitment was better 
than intended and continued to 92 eligible participants 
resulting in 65 participants starting the intervention.
Suitable numerical statistics and graphical summa-
ries were used to describe characteristics of the sample 
at baseline and to assess the validity of any distribu-
tional assumptions needed for the formal analysis. All 
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tests of significance were two-sided and conducted at an 
alpha=0.05 level of statistical significance. An exploratory 
paired t-test between baseline and each of the week 12, 24 
and 36 follow-ups was conducted, providing a summary of 
the effects of the estimated treatment and control from 
the raw data. These ‘unadjusted’ results do not account 
for the patient covariates and repeated measurements. 
We also quantified and compared the magnitude of 
change in walking measures using Hedges’ G effect sizes 
and associated 95% CIs using Cohen’s conventions for 
effect sizes (0.2 small, 0.5 moderate, 0.8 large). For each 
outcome measure, the mean baseline to postintervention 
and 3-month and 6-month change for the control condi-
tion was subtracted from the mean baseline to postinter-
vention and 3 and 6 month change for the intervention 
condition and divided by the pooled baseline SD.30 Effect 
sizes were calculated such that greater improvements in 
outcomes in the intervention group compared with the 
control group resulted in positive effect sizes.
The statistical modelling compared differences in 
the response variables (6MWT, TUG and MSWS scores) 
between the two intervention arms at each of the three 
postintervention follow-ups while correcting for the base-
line measurements for each participant. A linear mixed 
model for a continuous response over time due to the 
two interventions, while adjusting for participant-specific 
covariates and factors, namely 6MWT at baseline, age, 
gender, time since diagnosis and MS type (ie, benign, 
primary progressive and relapsing-remitting). Treat-
ment and time (and their interaction) were specified as 
fixed effects, centre (three levels) and subject (nested in 
centre) as random effects in order to account for homo-
geneity within centre and within subject correlation over 
time. Initially a model containing the main effects of the 
treatment, time and a treatment-by-time interaction was 
specified in order to test whether there is evidence that 
the treatment effects varies over time. If the interaction 
was deemed unnecessary (using a likelihood ratio test), 
the model was refitted excluding the interaction term, 
so the treatment effect was then constant over time. Two 
separate analyses were carried out. First, following an 
intention-to-treat principle in which all 65 patients who 
remained eligible to participate were considered. In the 
secondary analysis, a smaller cohort of 52 patients are 
analysed, who were identified to have closely adhered 
to the programme by having attended at least two of the 
three follow-ups. All models were fitted in R 3.2.0 using 
the lme4 and lmerTest packages. Model diagnostics 
involved suitable plots of the residuals.
results
Participant sample
One hundred and seventy-four PwMS contacted the trial 
centre and were screened for inclusion over the phone 
between September 2013 and May 2014. Eighty-two people 
were excluded as per the selection criteria (figure 1) and 
recruitment ceased when 92 people were randomised to 
either of the trial arms. Between time of randomisation 
and initiation of the intervention, 27 eligible participants 
either became ineligible or were unable to participate. 
One participant was not treated as randomised (two 
acquaintances had been randomised to the other group 
and they wanted to exercise with them). Sixty-five partic-
ipants commenced the intervention (SCT group, n=33; 
CON group, n=32). In the SCT group, four participants 
discontinued the intervention and 12 were lost to follow-up 
at 36 weeks. In the CON group, three participants discon-
tinued the intervention and 10 were lost-to-follow up at 
36 weeks. Following the 10-week intervention, overall 
attrition was 17% and at the 36-week follow-up assessment 
attrition was 34%. Reasons for discontinuing the interven-
tion and loss to follow-up are outlined in figure 1. Baseline 
characteristics for both groups are shown in table 1.
treatment fidelity
An independent person to the intervention (PO’S) 
used the manual of operating procedures to check if the 
required content of the programme (both exercise and 
SCT/attention control education components) was deliv-
ered as intended. In both trial arms, 100% of the content 
of the supervised sessions were implemented as described 
in the intervention manual.
Feasibility—exercise logs
The development of hip pain by one participant in the 
CON group was the only related adverse event reported 
by participants in both trial arms during the comple-
tion of the 10 week intervention. The SCT and the 
CON groups completed an average of 33.2 of 44 avail-
able sessions (75.5%) and 32.0 sessions (72.6%), respec-
tively. The proportion of sessions completed is presented 
in figure 2, where the lowest number of sessions was in 
week 7 when participants were exercising independently 
without a class for a second consecutive week. Among the 
53 participants who provided detailed exercise logs, 17 
(68%) of the SCT group and 14 (50%) of the CON group 
were exercising at the minimum recommended by the 
exercise guidelines by the end of the 10-week interven-
tion. The reasons for not meeting the guideline included: 
walking less than 30 min twice per week (SCT, n=3; CON, 
n=1), walking only once per week (SCT, n=2; CON, n=5) 
and doing only one set of each resistance exercise per 
week (SCT, n=2; CON, n=4).
In order to further evaluate the adherence to the inter-
vention we investigated the change in strength, fitness 
and PA in order to evaluate whether the intervention 
changed these intended parameters. Table 2 presents the 
raw data and unadjusted comparisons. For both groups, 
there were significant improvements in PA and strength 
from weeks 1 to 12. There was a tendency for aerobic 
fitness scores to increase, but this change was not statisti-
cally significant.
Walking mobility
The mean (SD) scores for the 6MWT, TUG and MSWS-12 
at weeks 1, 12, 24 and 36 for participants in the exercise 
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Figure 1 CONSORT flow diagram.
plus SCT and exercise plus education control groups are 
presented in table 3. Figure 3 shows the results of the esti-
mated treatment effects on 6MWT, TUG and MSWS-12, 
as per intention-to-treat and secondary analyses, respec-
tively. The unadjusted, unstandardised mean changes 
from baseline, and 95% CIs and paired t-test results for 
both groups are presented in table 4 along with Hedges’ 
G effect sizes. Both groups demonstrated an improvement 
in the primary outcome, 6MWT and secondary outcome 
MSWS from weeks 1 to 12 and at 24-week and 36-week 
follow-up. For TUG the result are a little more mixed, 
with evidence of an improvement in both groups from 
weeks 1 to 12 which diminishes in the control group by 
week 36 but a persistent significant difference is observed 
in the education with SCT group from baseline to weeks 
24 and 36.
The linear mixed models results in table 5 shows that 
using an intention-to-treat analysis there was no evidence 
of a significant treatment effect in favour of the exer-
cise plus SCT compared with the exercise only group 
for regarding 6MWT, TUG or MSWS scores. Figure 3 
confirms the obvious significant effects of the exercise 
programme found above in the unadjusted paired t-test 
results, which is shown by the blue and red lines being 
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Table 1 Clinical baseline characteristics in exercise plus 
SCT group (SCT) and exercise plus education control group 
(CON)
SCT (n=33) CON (n=32)
MS type
  Benign 3 1
  Primary progressive 1 0
  Relapsing-remitting 27 27
  Secondary progressive 0 1
  Unknown 2 2
EDSS (median, IQR) 3.3 (0.7) 3.3 (0.7)
Years since diagnosis 6.7 (5.7) 7.0 (6.1)
Centre (n)
  Cork 10 9
  Galway 8 10
  Limerick 15 13
Age 43.3 (9.9) 41.9 (9.3)
Gender (n)
  Male 4 6
  Female 29 26
Data given as mean (SD) unless otherwise indicated.
EDDS, Expanded Disability Disease Scale; MS, multiple sclerosis.
Figure 2 Proportion of participants completing sessions 
(Exercise Diary data).
well above the black ‘no effect’ line when the sample 
uncertainty conveyed by the corresponding CIs are taken 
into account. But figure 3 also confirms lack of evidence 
for an additional effect of the SCT over the usual exercise 
programme, which is shown by the widely overlapping CIs 
between the treatment and control groups.
A secondary analysis was completed with participants 
who attended at least two of the three follow-up assess-
ments (SCT n=25, CON n=27). Table 3 presents the 
mean (SD) scores for the 6MWT, TUG and MSWS-12 at 
weeks 1, 12, 24 and 36 for participants in the SCT and 
control groups using secondary analysis. For 6MWT, the 
SCT group had a marginally more positive outcome, with 
statistically significant treatment effects evident at weeks 
12 and 36 (table 5). Using this secondary analysis, there 
was no evidence of a treatment effect in favour of the SCT 
group as compared with the CON group regarding the 
TUG or MSWS-12 scores.
DIscussIOn
This pilot RCT investigated the feasibility and preliminary 
efficacy of the Step it Up programme, a 10-week aerobic 
and strengthening programme that aimed to enable phys-
ically inactive PwMS to exercise according to the recent 
MS exercise guidelines.8 We investigated whether embed-
ding an evidence-based exercise programme within a 
structured SCT-based education programme resulted 
in improved and more sustained walking outcomes 
compared with an exercise plus attention control educa-
tion intervention. To our knowledge, this is the first study 
to examine the effect of enabling inactive people to meet 
the minimum recommended dose of the MS exercise 
guidelines and examine the effects on walking mobility as 
a primary end-point.
The intervention protocol was feasible and results 
demonstrated significant improvements in walking 
mobility following the intervention in both groups. 
There was a moderate effect (Hedges’ G 0.50) at 36-week 
follow-up in favour of the SCT group for 6MWT. The 
effect for the SCT group was also greater at 12-week 
and 36-week follow-up for the primary outcome, 6MWT, 
using the secondary analysis which included only patients 
who adhered to the programme (as defined by having 
attended at least two of the three follow-ups). Recruit-
ment was successful and over 9 months at three centres, 
we recruited more than our target of 62 participants (92 
eligible participants). The largest point of attrition was 
while participants waited for enough people to run the 
group in that region. In the future, recruiting from the 
largest city in Ireland for a definitive RCT will enable 
greater numbers to be recruited more quickly and should 
minimise this attrition at this point in the trial. Retention 
across the intervention period was good and the attrition 
rate (17%) was similar to other exercise interventions 
in people with depression31 and slightly higher than the 
average of 15% in a review of exercise trials in MS.32 While 
the level of participant attrition in the current programme 
is greatly improved from our previous community based 
exercise RCT,9 10 measures such as recruiting a dedicated 
study coordinator to provide more frequent interactions 
with participants in the definitive trial will be explored to 
further enhance retention at follow-up. The addition of 
booster intervention sessions after the completion of the 
10-week intervention will also be explored in the future 
definitive trial.
The intervention was delivered by physiotherapists who 
attended a 1-day training session and treatment fidelity 
findings suggest that this approach was successful as the 
interventions were delivered as intended; further training 
and support may increase the success of the intervention 
in future. Participants completed on average 73%–75% 
group.bmj.com on October 17, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 7Hayes S, et al. BMJ Open 2017;7:e016336. doi:10.1136/bmjopen-2017-016336
Open Access
Table 2 Raw data and unadjusted comparisons of change in secondary outcomes from week 1 to week 12 in exercise plus 
SCT group (SCT) and exercise plus education control group (CON)
Week 1
Mean (SD)
Week 12
Mean (SD)
Mean change from week 1 to week 12 
(95% CI) p Value
Godin Health Index SCT 3.03 (6.19) 12.48 (11.15) 9.85 (5.46 to 14.23) p<0.01
CON 1.88 (4.88) 16.07 (21.12) 12.92 (4.96 to 20.89) p<0.01
Five Times Sit to Stand SCT 11.48 (2.7) 9.78 (2.18) −1.51 (−2.42,–0.60) p<0.01
CON 10.8 (2.6) 9.43 (1.93) −1.55 (−2.30 to –0.79) p<0.01
Aerobic Fitness Score SCT 295.72 (54.61) 309.12 (53.78) 8.58 (−6.86 to 23.98) p=0.26
CON 313.56 (59.02) 331.29 (51.57) 10.54 (−6.29 to 27.37) p=0.21
Table 3 Mean (SD) walking mobility outcomes at weeks 1, 12, 24 and 36 in exercise plus SCT group (SCT) and exercise plus 
education control group (CON)
Outcome 
variable
Week 1 Week 12 Week 24 Week 36
SCT CON SCT CON SCT CON SCT CON
Intention-to-treat analysis
6MWT 445.2
(68.8)
482.0
(72.0)
527.4
(91.1)
547.1
(96.0)
492.8
(73.5)
504.9
(76.9)
515.8
(91.0)
528.0
(93.2)
TUG 7.06
(1.61)
6.51
(1.36)
6.27
(1.45)
5.81
(1.08)
6.23
(1.26)
6.00
(0.98)
5.93
(1.33)
5.96
(1.20)
MSWS-12 38.0
(28.0)
33.3
(24.8)
29.6
(22.2)
30.8
(21.3)
31.9
(22.1)
26.3
(21.5)
32.6
(23.4)
27.9
(21.9)
Secondary analysis
6MWT 434.6
(65.2)
474.4
(69.6)
524.2
(96.7)
535.2
(88.0)
496.2
(73.7)
504.9
(76.9)
515.8
(91.0)
528.0
(93.2)
TUG 7.08
(1.73)
6.65
(1.36)
6.43
(1.46)
5.87
(1.13)
6.30
(1.25)
6.00
(0.98)
5.93
(1.33)
5.96
(1.20)
MSWS-12 38.2
(26.7)
31.9
(22.6)
29.7
(22.6)
32.6
(21.0)
31.9
(22.1)
26.3
(21.5)
32.6
(23.4)
27.0
(21.8)
MSWS-12, Multiple Sclerosis Walking Scale-12; 6MWT, Six-Minute Walk Test; TUG, Timed Up and Go. 
of possible sessions suggesting that the protocol is feasible 
for participants with minimal impairment due to MS. 
We collected data from exercise logs for demonstrating 
adherence with the exercise programme. The exercise 
logs were returned by 82% of participants and used to 
ascertain whether participants were meeting the MS exer-
cise guideline at the end of the intervention period. It 
is interesting to note that a greater proportion of partic-
ipants in the SCT group (68% vs 50%) progressed to 
meeting the guidelines. Measures to further enhance 
completion and return of logs (such as offering them in 
alternative electronic formats) in the future definitive 
trial are needed.
We further confirmed adherence to this aerobic and 
strengthening intervention by investigating its effects on 
strength, fitness and PA. Both 5xSTS and Godin Health 
index increased significantly and the Aerobic Fitness 
Scale (AFS) showed a tendency to improve providing 
evidence that the exercise intervention met its intended 
outcomes. Collectively, we believe that the exercise log 
data combined with fitness and PA outcomes support the 
successful manipulation of exercise behaviour with in both 
trial arms. Based on the data on recruitment, retention, 
feasibility and preliminary efficacy of this group exercise 
and SCT education intervention, we propose to progress 
to a definitive intervention. To do this, a sample of 49 
(for a difference between groups of 39 m, assuming a SD 
of the change score at 36 weeks of 67.85, 80% power, 0.05 
significance level) in each group would be needed and we 
therefore plan to recruit across these three centres again 
and to add a fourth centre in the largest city in Ireland to 
minimise attrition.
Importantly, both groups improved significantly in the 
primary outcome, 6MWT, following the intervention. 
This improvement in 6MWT is consistent with a recent 
systematic review of exercise studies that found a signif-
icant improvement in walking endurance.7 We note that 
the mean improvement in the SCT group of 80 m and of 
60 m in the control group far exceeded the value for the 
clinically important change of 26.1 m proposed by Baert 
et al.29 Both groups improved more than that reported by 
Carter et al33 in their exercise plus education group, and 
the magnitude of improvement is more consistent with 
the improvements noted in a recent community-based 
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Figure 3 Estimated effects using intention-to-treat and secondary analyses. MS, multiple sclerosis.
intervention among people with moderate-severity MS.34 
We further note that the current physically inactive sample 
of PwMS with an average age of 42 had 6MWT of 445 m 
at baseline that was less than that of a reference sample 
aged 70–80 years who walked an average of 514 m35. This 
confirms the significant walking impairments for inac-
tive people with mild disability with MS and importantly 
demonstrates positive improvements due to the Step it 
Up exercise intervention. Interestingly, the SCT group 
but not the CON group improved in their self-reported 
walking impairment (MSWS-12) and the magnitude of 
the change in 6MWT distance may have influenced that 
finding. Both groups however improved in walking speed 
and maintained that improvement at 36-week follow-up 
with a small-moderate effect size in favour of the SCT 
group demonstrated for TUG.
Of note, through the secondary analysis including 
participants who participated in at least two follow-up 
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Table 5 Estimated treatment effects at weeks 12, 24 and 
36 in primary outcome
Estimate of 
difference 
between SCT 
and Control SE 95% CI p Value
Intention-to-treat analysis
  6MWT
   Week 12 22.70 19.00 (−15.14 
to 60.50)
0.23
   Week 24 11.80 20.40 (−28.77 
to 52.36)
0.56
   Week 36 27.42 20.35 (−13.06 
to 67.90)
0.18
   TUG
   Week 12 0.069 0.236 (−0.402 
to 0.541)
0.77
   Week 24 −0.132 0.250 (−0.630 
to 0.365)
0.60
   Week 36 −0.457 0.252 (−0.960 
to 0.045)
0.08
  MSWS-12
   Week 12 −4.91 4.47 (−13.82 
to 4.00)
0.28
   Week 24 −0.59 4.69 (−9.91 
to 8.73)
0.90
   Week 36 0.38 4.57 (−8.71 
to 9.47)
0.93
Secondary analysis
  6MWT
   Week 12 39.00 18.44 (2.26 to 
75.73)
0.04
   Week 24 27.44 19.23 (−10.82 
to 65.70)
0.16
   Week 36 40.03 18.97 (2.27 to 
77.79)
0.04
  TUG
   Week 12 0.204 0.255 (−0.306 
to 0.713)
0.43
   Week 24 −0.020 0.261 (−0.542 
to 0.502)
0.94
   Week 36 −0.367 0.262 (−0.890 
to 0.156)
0.17
  MSWS-12
   Week 12 −7.63 4.65 (−16.89 to 
1.63)
0.11
   Week 24 −2.50 4.78 (−12.01 
to 7.02)
0.60
   Week 36 −1.57 4.69 (−10.93 
to 7.78)
0.74
MSWS-12, Multiple Sclerosis Walking Scale-12; 6MWT, Six-Minute 
Walk Test; TUG, Timed Up and Go.
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assessments, we demonstrated that adding a structured 
SCT education programme enhanced the effect on 
6MWT distance following the 10-week intervention. This 
is important as it provides information on the prelimi-
nary effectiveness of the intervention and confirms the 
need to augment the retention strategies in the definitive 
trial. We propose greater training for the interventionists 
and greater use of telephone coaching in weeks without 
classes and between intervention and follow-up sessions. 
Importantly, both the improvement from baseline and 
the difference in between-group effects were maintained 
at 36-week follow-up providing new information on the 
ability to sustain effects after the intervention ceased. 
Interestingly, the effect was reduced at 24 weeks and 
participants reported that realising they had deteriorated 
at that assessment served as a prompt to resume their exer-
cise after that assessment. The SCT education programme 
had six education sessions that targeted outcome expec-
tancies, self-efficacy, goal setting and perceived barriers 
and benefits of exercise. The components are further 
consistent with a recent systematic review and meta-anal-
ysis of modifiable psychosocial constructs associated with 
PA in MS that confirmed self-efficacy, goal setting and 
outcome expectancies as significantly correlated with PA 
in MS.36 One novel feature of the current trial is that the 
SCT education modules were delivered by physiothera-
pists with minimal training in delivery of behavioural 
interventions. These findings also support that delivering 
this SCT education intervention by physiotherapists in a 
group setting is both feasible and preliminary findings 
suggest that it may have superior outcomes to an atten-
tion control education intervention.
strengths and limitations
One of the strengths of this pilot RCT relates to the 
production of new knowledge around the sustainability 
of exercise interventions for PwMS. Building on the 
existing evidence base, we designed and delivered a 
SCT-based pragmatic physiotherapist-led community 
exercise. Results demonstrated the feasibility of the 
protocol among physically inactive people with mild MS 
and trends towards clinical efficacy for walking outcomes. 
The model of care outlined in this pilot study presents as a 
highly scalable intervention package for physiotherapists 
and other healthcare professionals working in primary 
care services or with third sector organisations (charities). 
Further study in the form of a definitive trial, including 
cost and clinical outcomes has the potential to have real 
policy implications for the provision of rehabilitation to 
PwMS. Further strengths relate to the use of measures 
of treatment fidelity, target variables of the intervention 
(strength, fitness and PA) and both self-report (MSWS) 
and objective (TUG and 6MWT) measures of walking. 
Additionally, in the context of an evidence base where 
PA interventions are often not theoretically based, a key 
strength of this RCT is the use of the SCT framework to 
design a behaviour-change intervention; building on the 
extensive work of the US partner in this trial.
One limitation is the attrition of participants between 
point of eligibility and allocation to the intervention. The 
large waiting times resulted in the loss of 29% of eligible 
participants at this point in the trial. Recruitment from 
larger urban areas with greater numbers of both MS 
clinics and  PwMS is planned for the future definitive 
trial so that the numbers required to run group classes 
are met more quickly. A further positive is that we used 
pedometers and exercise logs to record the intensity and 
duration of the intervention; however, another limitation 
is that detailed exercise diaries were not returned for all 
participants. However, a return rate of 82% is acceptable 
and measures to improve this in the definitive trial will be 
considered.
cOnclusIOn
This pilot RCT aimed to investigate the feasibility and 
preliminary efficacy of enabling physically inactive PwMS 
to meet the MS exercise guidelines8 through a group 
exercise and education, physiotherapist-led intervention. 
We further sought to investigate whether the theory-based 
SCT component was superior to an attention control 
education intervention. We found that recruitment was 
successful, though measures to improve retention in a 
future definitive trial are needed. Attrition over the inter-
vention and follow-up periods were improved compared 
with our previous exercise trial.9 The programme 
resulted in significant improvements in walking endur-
ance and speed for both groups. There was a moderate 
effect (Hedges’ G 0.50) for 6MWT at 36 weeks which 
is supported by a secondary analysis of those with data 
for three of four assessment points which demonstrated 
there was a significant effect in favour of the exercise 
plus SCT groups compared with the exercise plus control 
education group at weeks 12 and 36. This supports the 
preliminary sustained efficacy of the intervention and we 
propose progressing to a definitive intervention.
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